ASPIRE BIOPHARMA HOLDINGS, INC. (ASBPW) Operating income 2024–2025
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBPW) annual operating income history from SEC filings — each fiscal year as reported.
-$19.4MFY2025 · since FY2024: -$1.2M → -$19.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$19.4M | -1498.1% |
| FY2024 | -$1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ASBPW financial trends
ASBPW RevenueASBPW Net incomeASBPW Net marginASBPW Gross profitASBPW Gross marginASBPW Operating marginASBPW Operating cash flowASBPW Free cash flowASBPW Capital expendituresASBPW Return on equityASBPW Stock buybacksASBPW Dividends paidASBPW Total assetsASBPW Total liabilitiesASBPW Shareholders’ equityASBPW overview →